An ethical argument in favour of routine hepatitis B vaccination in very low-incidence countries

Lancet Infectious Diseases

Volumn 5, Issue 2, 2005, Pages 120-125

  Dawson, Angus J ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE;

CHILDHOOD; COST EFFECTIVENESS ANALYSIS; DRUG COST; EUROPE; GREECE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MEDICAL ETHICS; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SCREENING; SIDE EFFECT; UNITED KINGDOM; UNITED STATES; VACCINATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 12944299289     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70087-6     Document Type: Review

References (33)

1. WHO. Hepatitis B fact Sheet WHO/204. Geneva: WHO, 2000. http://www.who.int/inf-fs/en/fact204.html (accessed September 23, 2004).
2. WHO. Hepatitis B. Geneva: WHO, 2002. http://www.who.int/emc-documents/ hepatitis/docs/whocdscsrlyo20022.pdf (accessed September 23, 2004).
3. Beutels P. Economic evaluations of hepatitis B immunization: a global review of recent studies (1999-2002). Health Econ. 10:2001;751-774
4. Department of Health. Getting ahead of the curve. A strategy for combating infectious diseases. 2002;DoH, London
5. Anon. Incidence of acute hepatitis B-United States. 1990-2002. Morb Mort Wkly Rep 2004; 52: 1252-54.
6. de Franchis R, Hadengue A, Lau G, et al. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (long version). J Hepatol. 39:(suppl 1):2003;S3-S25
7. Health Education Authority. A guide to childhood immunisations. 1997;HEA, London
8. Department of Health. Website information about hepatitis B. http://www.doh.gov.uk/hepatitisb/index.htm (accessed September 14, 2004).
9. Salisbury DM, Begg NT eds. Immunisation against infectious disease. London: HM Stationery Office, 1996
10. Hahne S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 29: 211-220.
11. Grosheide P, Van Damme P. Prevention and control of hepatitis B in the community. Hallauer J, Kane M, McCloy E, Meheus A, Roure C. Communicable Diseases Series. 1996;64 University of Antwerp, Antwerp
12. Foundation for Liver Research. Hepatitis B: out of the shadows. A report into the impact of hepatitis B on the nation's health. London: Foundation for Liver Research, 2004. http://www.ucl.ac.uk/liver-research (accessed September 24, 2004).
13. Edmunds WJ, Dejene A, Mekonnen Y, Haile M, Alemnu W, Nokes DJ. The cost of integrating hepatitis B virus vaccine into national immunization programmes: a case study from Addis Ababa. Health Policy Plan. 15:2000;408-416
14. Aggarwal R, Ghoshal U, Naik S. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J Hepatol. 38:2003;215-222
15. Mangtani P, Hall AJ, Normand CEM. Hepatitis B vaccination: the cost-effectiveness of alternative strategies for England and Wales. J Epidemiol Comm Health. 49:1995;238-244
16. Fenn P, Gray A, McGuire A. An economic evaluation of universal vaccination against hepatitis B virus. J Infect. 32:1996;197-204
17. Williams JR, Nokes DJ, Anderson RM. Targeted hepatitis B vaccination - cost-effectiveness immunisation strategy for the UK? J Epidemiol Comm Health. 50:1996;667-673
18. Edmunds WJ. Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies. Commun Dis Public Health. 1:1998;221-228
19. Beutels P. Economic evaluation of vaccination programmes in humans. 2002;University of Antwerp, Antwerp
20. UNICEF. Supply Division annual report 2002. 2002;UNICEF Supply Division, Copenhagen
21. Fendrick AM, Lee JH, LaBarge C, Glick HA. Clinical and economic impact of a combined haemophilus influenzae and hepatitis B vaccine: estimated cost-effectiveness using decision analysis. Arch Pediatr Adolesc Med. 153:1999;126-136
22. Aristegui J, Usonis V, Coovadia H, et al. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis. 7:2003;143-151
23. Institute of Medicine, Vaccines for the 21st century: a tool for decision making. Washington DC: National Academies Press, 1999.
24. Verweij M, Dawson A. Ethical principles for collective immunisation programmes. Vaccine. 22:2004;3122-3126
25. Gjorup IE, Skinhoj P, Bottinger B, Plesner A. Changing epidemiology of HBV infection in Danish children. J Infect. 47:2003;231-235
26. Ota M, Vekemans J, Schlegel-Haueter SE, et al. Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine. 22:2004;511-519
27. Armstrong GL, Mast E, Wojczynski M, et al. Childhood hepatitis B virus infections in the United States before hepatitis B immunization. Pediatrics. 108:2001;1123-1128
28. Elliman D, Bedford H. Safety and efficacy of combination vaccines. BMJ. 326:2003;995-996
29. van Steenbergen JE. Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners. J Hepatology. 37:2002;507-513
30. Rhodes SD, Hergenrather KC. Exploring hepatitis B vaccination acceptance among young men who have sex with men: facilitators and barriers. Prev Med. 35:2002;128-134
31. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States, Need for alternative vaccination strategies. JAMA. 263:1990;1218-1222
32. Papaevangelou G. Hepatitis B immunization programme: lessons learnt in Greece. Vaccine. 16:(suppl 1):1998;S45-S47
33. Health Protection Agency. Shooting up: infections among injecting drug users in the United Kingdom 2002. 2003;Health Protection Agency, London